GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the oversold stocks to buy now. On January 5, Bank of America analyst Allen Lutz ...

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and telehealth services, finds itself at a critical juncture. As the company ...

GoodRx is generating solid profitability with growth in monthly active consumers to its prescription drugs discount platform. Management expects stronger trends into the second half of the year. The ...

The stock market is in free fall right now, but it's far worse for shares of prescription-drug discounter GoodRx (NASDAQ: GDRX). The company reported financial results for the first quarter of 2022 ...

Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.7% in the afternoon session after investor enthusiasm continued following its recent partnership with Danish pharmaceutical giant Novo ...

GoodRx addresses many challenges in the U.S. healthcare space. GoodRx's tech-enabled solutions are proving to be an immense value-add as their platforms have built great trust with their consumers.

You already know the economic recovery from the pandemic is going to be great for travel, dining, and entertainment, but it's also going to be great for a surprising sector: healthcare. As the ...

The new stock first hit the markets on September 23. Telemedicine is rising in popularity during the coronavirus pandemic, and it's been a hot place to invest in this year. Look no further than ...